
Press releases
2023
30 May 2023, 08:00
29 May 2023, 16:00 | Regulatory
20 Apr 2023, 08:00 | Regulatory
· Positive reimbursement decision in Spain expands market access to include the five largest European markets
· Enrollment in phase 2 study of imlifidase in Guillain-Barré Syndrome (GBS) completed
· HNSA-5487: Phase 1 clinical study started in healthy volunteers
14 Apr 2023, 08:00
31 Mar 2023, 08:00
30 Mar 2023, 08:00 | Regulatory
